VAXCYTE INC (PCVX) Stock Earnings & Estimates
NASDAQ:PCVX - US92243G1085 - Common Stock
31.97 USD
+1.18 (+3.83%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 250.62% | N/A 398.71% | N/A 73.91% | N/A 26.52% | N/A 26.84% | |||||||||
| EBITDA YoY % growth | -17.2M | -34.49M -100.52% | -52.92M -53.44% | -88.17M -66.61% | -101.87M -15.54% | -206.68M -102.89% | -382.87M -85.25% | -553.701M -44.62% | N/A -20.47% | N/A -10.19% | N/A -2.44% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.83M | -35.53M -99.27% | -54.15M -52.41% | -89.58M -65.43% | -103.67M -15.73% | -209.26M -101.85% | -393.041M -87.82% | -569.546M -44.91% | N/A -48.89% | N/A -11.55% | N/A 0.56% | N/A 17.63% | N/A 141.25% | N/A 311.75% | N/A 22.11% | N/A 38.71% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -1.93 70.08% | -3.43 -77.72% | -4.13 -20.41% | -3.79 8.14% | N/A -31.36% | N/A -19.06% | N/A -3.86% | N/A 5.78% | N/A 66.01% | N/A 338.07% | N/A 78.44% | N/A 29.77% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.33 -60.07% | -1.40 -38.16% | -1.47 -41.23% | -1.58 -29.17% | -1.65 -24.38% | -1.69 -20.86% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | -157.661M -22.35% | -163.506M -11.74% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -212.596M -51.94% | -220.232M -35.80% | -223.533M -23.64% | -239.343M -5.80% | -242.25M -13.95% | -244.8M -11.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.22 -10.91% | -1.19 | -0.03 | -2.10% |
| Q1 2025 Q2Q % growth | -1.04 -22.35% | -1.07 | 0.03 | 2.74% |
| Q4 2024 Q2Q % growth | -1.01 44.29% | -1.16 | 0.15 | 12.92% |
| Q3 2024 Q2Q % growth | -0.83 8.79% | -1.16 | 0.33 | 28.30% |
| Q2 2024 Q2Q % growth | -1.10 -57.14% | -1.00 | -0.10 | -9.49% |
| Q1 2024 Q2Q % growth | -0.85 -21.43% | -1.19 | 0.34 | 28.70% |
| Q4 2023 Q2Q % growth | -1.82 -78.43% | -1.09 | -0.73 | -66.45% |
| Q3 2023 Q2Q % growth | -0.91 2.15% | -0.85 | -0.06 | -6.53% |
| Q2 2023 Q2Q % growth | -0.70 12.50% | -0.76 | 0.06 | 7.88% |
| Q1 2023 Q2Q % growth | -0.70 -2.94% | -0.84 | 0.14 | 16.89% |
| Q4 2022 Q2Q % growth | -1.02 -85.45% | -0.95 | -0.07 | -7.53% |
| Q3 2022 Q2Q % growth | -0.93 -82.35% | -0.85 | -0.08 | -8.98% |
| Q2 2022 Q2Q % growth | -0.80 -73.91% | -0.70 | -0.10 | -13.67% |
| Q1 2022 Q2Q % growth | -0.68 -65.85% | -0.64 | -0.04 | -6.38% |
| Q4 2021 Q2Q % growth | -0.55 -34.15% | -0.57 | 0.02 | 3.71% |
| Q3 2021 Q2Q % growth | -0.51 -24.39% | -0.56 | 0.05 | 8.54% |
| Q2 2021 Q2Q % growth | -0.46 73.26% | -0.53 | 0.07 | 13.82% |
| Q1 2021 Q2Q % growth | -0.41 | -0.49 | 0.08 | 17.12% |
| Q4 2020 Q2Q % growth | -0.41 | -0.55 | 0.14 | 25.56% |
| Q3 2020 Q2Q % growth | -0.41 | -0.45 | 0.04 | 9.33% |
| Q2 2020 Q2Q % growth | -1.72 | -1.29 | -0.43 | -33.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2020 Q2Q % growth | 255K | -255K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.51% | -15.78% | -2.28% | -1.13% |
| Revenue | N/A | N/A | N/A | N/A |